The Protective Mechanism of ApoE3 R136S in Alzheimer’s Disease: A New Hope for Neurodegeneration
- 3 July 2025
- journal article
- editorial
- Published by Springer Nature in Phenomics
- Vol. 5 (4) , 1-2
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82471445)
- National Natural Science Foundation of China (32170988)
- the grant from the Startup Foundation for Introducing Talent of Lanzhou University (561120215)
This publication has 9 references indexed in Scilit:
- ApoE3 R136S binds to Tau and blocks its propagation, suppressing neurodegeneration in mice with Alzheimer’s diseaseNeuron, 2025
- Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategiesSignal Transduction and Targeted Therapy, 2024
- The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammationNature Neuroscience, 2023
- Trial of Solanezumab in Preclinical Alzheimer’s DiseaseNew England Journal of Medicine, 2023
- Emerging diagnostics and therapeutics for Alzheimer diseaseNature Medicine, 2023
- The probabilistic model of Alzheimer disease: the amyloid hypothesis revisedNature Reviews Neuroscience, 2021
- Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer DiseaseJAMA Neurology, 2021
- APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approachesThe Lancet Neurology, 2021
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002